NCT00259896View on ClinicalTrials.gov

In-patient Study in Patients With Type 2 Diabetes Mellitus

PHASE1CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

October 31, 2005

Conditions
Type 2 Diabetes MellitusDiabetes Mellitus, Type 2
Interventions
DRUG

exenatide

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY

NCT00259896 - In-patient Study in Patients With Type 2 Diabetes Mellitus | Biotech Hunter | Biotech Hunter